IBD India is a registered non-profit founded to ensure that no person living with Inflammatory Bowel Disease in India has to navigate the journey alone.
IBD Patient Support Foundation (India), also known as IBD India, is a registered non-profit organisation working to support persons with Inflammatory Bowel Diseases (IBD) in India. We also share our resources to support patients from other low and middle income countries such as Nepal, Bangladesh, and Ethiopia.
Founded in April 2020, we began by creating India's first public repository of IBD content — expert interviews, patient stories, and panel discussions — to fill a critical gap in reliable, accessible information for patients.
Over the years, we have expanded to offer free mental health counseling, a national doctor directory, medicine donation programmes, financial aid, and some of India's most active IBD patient communities.
We work in collaboration with national institutions like AIIMS New Delhi and the Colitis and Crohn's Foundation (India), as well as international partners across the US and Europe.
The Foundation is registered under Sections 12A and 80G. Donations made to IBD India can be claimed as deductions from taxable income.
We believe patients are the most powerful resource for each other. Everything we do is designed to connect people who understand what it means to live with IBD.
All patient-facing services are completely free. No fees, no insurance requirements. We remove every barrier we can between patients and the support they need.
IBD affects far more than the gut. We champion mental health, emotional wellbeing, and caregiver support alongside physical healthcare.
We collaborate with medical institutions and researchers to ensure everything we share is accurate, evidence-based, and trustworthy.
IBD does not discriminate. Our resources are available in Hindi and English, and we extend our support beyond India to patients in other low-income countries.
We represent patient voices at national and international forums — from CCFI conferences to Asia-Pacific IBD summits — to influence policy and care standards.